Home > NEWS > Industry News

Brazilian mushroom is rich in anti-tumor active ingredients

Brazil mushroom, scientific name Agaricus Blazei Murill, is rich in lentinan, which is 23.5 times that of common mushrooms. It has the function of “anti-cell mutation, tumor inhibition, and systemic regulation of immune function” and has attracted international attention. It is known as an international food medicine. Yukio Mizuo, an expert in the use of bacteria, was regarded as one of the "four major anti-cancer kings" by Shizuoka University in Japan. If Brazilian mushrooms are likened to gold ore, then lentinan is the gold that is purified from it. The use of lentinan is now recognized in the medical and pharmaceutical fields. In April of this year, the new anti-tumor scientific research achievement, Wuyue Lingzhibao, was taken over by a famous health care product company in Beijing and quickly brought to the market. It was triggered in major cities such as Beijing, Guangzhou, Shanghai, Xi’an, Shenyang and Changchun. An anti-tumor revolution!

In 1945, the Brazilian mushroom was first discovered by the American mycologist W.A. Murill. In the late 1960s, Japanese coffee growers in Brazil were introduced to Japan. In 1992, it was introduced by Japan into Fujian, China. Because of its harsh cultivation conditions and low yield, refined extracts as raw materials are expensive and cost 160,000 to 200,000 yuan per ton of dry goods. Brazil mushroom after nearly 30 years of research found that it can be extracted from the "anti-cell mutations, inhibition of tumors, systemic regulation of immune function," the active ingredient. Brazil mushroom, named after its origin in South America and Brazil, is rich in effective active substances such as lentinan and has a significant anti-tumor effect. It is known locally as Cogmelode Deus, “Mushroom of God”. In 1968, the Japanese scientist Chiwon Chihara had a large number of animal experiments found that lentinan extracted from the following functions: (1) significantly resist cell mutation, (2) inhibit tumor cell growth, (3) enhance immune function. After 17 years of basic research and scientific experiments in Japan, Japan's Ministry of Health and Welfare approved the production of a large number of imported lentinan injections in 1985. It has been used in the treatment of cancer patients and various diseases with low immune function, and has achieved good results. Subsequently, medical professional organizations around the world conducted in-depth research on the anti-cell mutation, inhibition of tumor cell growth, and two-way regulation of immune function of lentinan, and the development and application of the product have achieved remarkable clinical results and received widespread praise.

In 1988, with the approval of the Ministry of Health of the People's Republic of China, domestic imports of lentinan for the treatment of advanced cadre cancer patients, although significant effect, but due to expensive (at the time each content 4mg, priced at 500 yuan), Patients must be hospitalized, inconvenient to use, and other factors, so that ordinary people are out of reach. In recent years, domestic pharmaceutical companies have adopted technology, GMP compliance, and imitation of lentinan polysaccharides. After extensive clinical application, they have proved to be effective. They have been identified as new national anticancer drugs and listed in the National Essential Drug List. At present, the major therapeutic agents widely used in major hospitals are 1mg each and the price is 277 yuan. The cost of a course of treatment still costs more than 15,000 yuan. This has made many working-class patients have to wait for drugs to stop and look for drugs!